| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |